![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: CRBN (CAeditome ID:51185) |
Gene summary for CRBN |
![]() |
Gene information | Gene symbol | CRBN | Gene ID | 51185 |
Gene name | cereblon | |
Synonyms | MRT2|MRT2A | |
Cytomap | 3p26.2 | |
Type of gene | protein-coding | |
Description | protein cereblonprotein x 0001 | |
Modification date | 20210518 | |
UniProtAcc | Q96SW2 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
CRBN | GO:0005634 | Protein cereblon | 20223979 |
CRBN | GO:0005737 | Protein cereblon | 20223979 |
CRBN | GO:0031464 | Protein cereblon | 20223979 |
Top |
RNA A-to-I events for CRBN |
![]() |
![]() |
![]() |
![]() |
CAediting_254062(3151047, -), CAediting_254063(3151652, -), CAediting_254064(3151918, -), CAediting_254065(3151929, -), CAediting_254066(3152198, -), CAediting_254067(3152268, -), CAediting_254068(3152274, -), CAediting_254069(3152301, -), CAediting_254070(3152755, -), CAediting_254071(3155823, -), CAediting_254072(3156027, -), CAediting_254073(3156177, -), CAediting_254074(3156228, -), |
Top |
RNA editing positional annotations for CRBN using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
![]() |
CAeditome ID | Position | Variant type |
CAediting_254062 | chr3_3151047_- | splicing |
CAediting_254063 | chr3_3151652_- | ncRNA_intronic |
CAediting_254064 | chr3_3151918_- | ncRNA_intronic |
CAediting_254065 | chr3_3151929_- | ncRNA_intronic |
CAediting_254066 | chr3_3152198_- | ncRNA_intronic |
CAediting_254067 | chr3_3152268_- | ncRNA_intronic |
CAediting_254068 | chr3_3152274_- | ncRNA_intronic |
CAediting_254069 | chr3_3152301_- | ncRNA_intronic |
CAediting_254070 | chr3_3152755_- | ncRNA_intronic |
CAediting_254071 | chr3_3155823_- | ncRNA_exonic |
CAediting_254072 | chr3_3156027_- | ncRNA_exonic |
CAediting_254073 | chr3_3156177_- | ncRNA_exonic |
CAediting_254074 | chr3_3156228_- | exonic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
CAediting_254066 | chr3_3152198_- | SINE | Alu | AluSz6 |
CAediting_254067 | chr3_3152268_- | SINE | Alu | AluSz6 |
CAediting_254068 | chr3_3152274_- | SINE | Alu | AluSz6 |
CAediting_254069 | chr3_3152301_- | SINE | Alu | AluSz6 |
CAediting_254071 | chr3_3155823_- | SINE | Alu | AluJb |
CAediting_254072 | chr3_3156027_- | SINE | Alu | AluJb |
Top |
RNA A-to-I editing events in the alternative splicing sites for CRBN |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
IR | CAediting_254062 | chr3_3151047_- | 3151043:3151065 | 3SS | 0+2i | ATCTTTCCTTAATTTCTTAGGTA | 9.44 | ATCTTTCCTTAATTTCTTGGGTA | 1.48 |
![]() |
![]() |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for CRBN |
![]() * The grey color means N/A. |
![]() |
![]() |
![]() |
![]() * Click on the image to enlarge it in a new window. |
GBM.CAediting_254062.ENSG00000113851.CRBN.png ![]() |
Top |
Protein coding region RNA A-to-I editings for CRBN |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for CRBN |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_117844 | chr1_162342605_+ | ENSG00000113851.12 | ENST00000450014 | hsa-miR-556-3p | 3167517 | 3167523 | 7mer-m8 | 3167516 | 3167537 | 150 | -13.4 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for CRBN |
![]() * Click on the image to enlarge it in a new window. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
CAediting_254074 | ENST00000231948.7 | chr3_3156228_- | -537.50 | -536.90 | -537.50 |
CAediting_254074 | ENST00000424814.4 | chr3_3156228_- | -476.90 | -476.30 | -476.90 |
CAediting_254074 | ENST00000432408.5 | chr3_3156228_- | -538.60 | -538.00 | -538.60 |
CAediting_254071 | ENST00000488263.4 | chr3_3155823_- | -1143.00 | -1143.30 | -1144.60 |
CAediting_254072 | ENST00000488263.4 | chr3_3156027_- | -1142.80 | -1143.30 | -1144.60 |
CAediting_254073 | ENST00000488263.4 | chr3_3156177_- | -1145.30 | -1143.30 | -1144.60 |
CAediting_254074 | ENST00000488263.4 | chr3_3156228_- | -1144.70 | -1143.30 | -1144.60 |
CAediting_254071 | ENST00000491834.4 | chr3_3155823_- | -1404.20 | -1404.20 | -1406.00 |
CAediting_254072 | ENST00000491834.4 | chr3_3156027_- | -1403.60 | -1404.20 | -1406.00 |
CAediting_254073 | ENST00000491834.4 | chr3_3156177_- | -1404.70 | -1404.20 | -1406.00 |
CAediting_254074 | ENST00000491834.4 | chr3_3156228_- | -1407.10 | -1404.20 | -1406.00 |
CAediting_254074 | ENST00000482844.4 | chr3_3156228_- | -138.30 | -138.30 | -138.30 |
CAediting_254073 | ENST00000480249.4 | chr3_3156177_- | -122.90 | -123.30 | -125.80 |
CAediting_254074 | ENST00000480249.4 | chr3_3156228_- | -126.20 | -123.30 | -125.80 |
Top |
Relation with ADAR for CRBN |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for CRBN |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for CRBN |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for CRBN |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
CRBN | Q96SW2 | DB00480 | Lenalidomide | Protein cereblon | SmallMoleculeDrug | approved |
CRBN | Q96SW2 | DB08910 | Pomalidomide | Protein cereblon | SmallMoleculeDrug | approved |
CRBN | Q96SW2 | DB01041 | Thalidomide | Protein cereblon | SmallMoleculeDrug | approved|investigational|withdrawn |
Top |
RelatedDiseases for CRBN |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
CRBN | C1843942 | Mental Retardation, Autosomal Recessive 2 | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
CRBN | C0000771 | Abnormalities, Drug-Induced | 1 | CTD_human |
CRBN | C0026764 | Multiple Myeloma | 1 | CGI;CTD_human |
CRBN | C0265541 | Cranioschisis | 1 | CTD_human |
CRBN | C0497552 | Congenital neurologic anomalies | 1 | CTD_human |